Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IPHA Innate Pharma SA

盘前交易 05-10 06:37:06 EDT

2.51

-0.12

-4.68%

最高2.58	最低2.51	成交量1,088
今开2.53	昨收2.63	日振幅2.78%
总市值2.03亿	流通市值7,685万	总股本8,084万
成交额2,753	换手率0.00%	流通股本3,065万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IPHA","market":"US","secType":"STK","nameCN":"Innate Pharma SA","latestPrice":2.507,"timestamp":1715284800000,"preClose":2.63,"halted":0,"volume":1088,"delay":0,"floatShares":30654998,"shares":80841988,"eps":-0.104002,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.123,"latestTime":"05-10 06:37:06 EDT","open":2.53,"high":2.58,"low":2.507,"amount":2753.493101,"amplitude":0.027757,"askPrice":2.55,"askSize":500,"bidPrice":2.44,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.104002,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715347800000},"adr":0,"listingDate":1571284800000,"adjPreClose":2.52,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":2.507,"preClose":2.507,"latestTime":"16:15 EDT","volume":10,"amount":26.5,"timestamp":1715285733362},"volumeRatio":0.45618445768231924},"requestUrl":"/m/hq/s/IPHA/tweets","defaultTab":"tweets","newsList":[{"id":"2432607795","title":"Innate Pharma盘中异动 股价大跌6.10%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432607795","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432607795?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:20","pubTimestamp":1714659601,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日22时20分，Innate Pharma股票出现异动，股价快速下跌6.10%。截至发稿，该股报2.39美元/股，成交量610股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.04%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050222200287cb338b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050222200287cb338b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432577806","title":"Innate Pharma盘中异动 早盘快速上涨6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432577806","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432577806?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:36","pubTimestamp":1714570565,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时36分，Innate Pharma股票出现异动，股价大幅上涨6.58%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Cytomx Therapeutics, Inc.、Tg Therapeutics, Inc.、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为434.81%、36.48%、14.94%，振幅较大的相关个股有Carmell Corporation、Cytomx Therapeutics, Inc.、Palisade Bio, Inc.，振幅分别为21.50%、19.63%、14.93%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121360587e852b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121360587e852b3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431193518","title":"Innate Pharma盘中异动 快速跳水8.13%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431193518","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431193518?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:10","pubTimestamp":1714410606,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日01时10分，Innate Pharma股票出现波动，股价急速下挫8.13%。截至发稿，该股报2.26美元/股，成交量883股，换手率0.00%，振幅1.22%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.85%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043001100779250d28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043001100779250d28&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429593190","title":"Innate Pharma盘中异动 股价大跌5.98%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429593190","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429593190?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:31","pubTimestamp":1713879104,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时31分，Innate Pharma股票出现波动，股价快速跳水5.98%。截至发稿，该股报2.28美元/股，成交量326股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.84%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321314487a65a93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321314487a65a93&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428345993","title":"Innate Pharma盘中异动 早盘股价大跌8.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428345993","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428345993?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:31","pubTimestamp":1713360674,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时31分，Innate Pharma股票出现波动，股价急速下跌8.88%。截至发稿，该股报2.36美元/股，成交量3493股，换手率0.00%，振幅1.54%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Vanda Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Novabay Pharmaceuticals, Inc.涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为25.24%、21.96%、16.50%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Viracta Therapeutics, Inc.、Rani Therapeutics Holdings, Inc.，振幅分别为16.09%、15.75%、11.06%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213114878a121a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213114878a121a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428805373","title":"Innate Pharma盘中异动 下午盘快速拉升7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428805373","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428805373?lang=zh_cn&edition=full","pubTime":"2024-04-17 01:49","pubTimestamp":1713289740,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日01时49分，Innate Pharma股票出现异动，股价快速上涨7.02%。截至发稿，该股报2.59美元/股，成交量5956股，换手率0.01%，振幅2.48%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Palisade Bio, Inc.涨幅较大，Palisade Bio, Inc.、Jaguar Health, Inc.、Biorestorative Therapies, Inc.较为活跃，换手率分别为3215.63%、192.38%、151.83%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.、Palisade Bio, Inc.，振幅分别为101.94%、97.81%、92.07%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170149007920f8db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170149007920f8db&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426255632","title":"HC Wainwright & Co.：重申Innate Pharma(IPHA.US)评级，由买入调整至买入评级, 目标价11.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426255632","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426255632?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:46","pubTimestamp":1712835992,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Innate Pharma(IPHA.US)评级，由买入调整至买入评级, 目标价11.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111946368b101d53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404111946368b101d53&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426411726","title":"Innate Pharma盘中异动 股价大跌5.00%报2.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426411726","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426411726?lang=zh_cn&edition=full","pubTime":"2024-04-10 23:49","pubTimestamp":1712764189,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日23时49分，Innate Pharma股票出现异动，股价急速下跌5.00%。截至发稿，该股报2.47美元/股，成交量3414股，换手率0.00%，振幅0.38%。Innate Pharma股票所在的生物技术行业中，整体跌幅为1.23%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1874.62%、75.59%、44.23%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Nutriband Inc C/Wts 、Calidi Biotherapeutics, Inc.，振幅分别为87.61%、52.44%、39.88%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410234949791fb006&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410234949791fb006&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424178392","title":"Innate Pharma盘中异动 快速跳水5.45%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424178392","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424178392?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:32","pubTimestamp":1712237520,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时32分，Innate Pharma股票出现波动，股价大幅下挫5.45%。截至发稿，该股报2.43美元/股，成交量711股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Tc Biopharm  Plc、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.涨幅较大，Tc Biopharm  Plc、Effector Therapeutics, Inc.、Eiger Biopharmaceuticals, Inc.较为活跃，换手率分别为550.17%、30.00%、16.11%，振幅较大的相关个股有Tc Biopharm  Plc、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tevogen Bio Holdings Inc.，振幅分别为30.00%、14.29%、12.97%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040421320087de7757&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040421320087de7757&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424045793","title":"Innate Pharma盘中异动 股价大跌5.97%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424045793","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424045793?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:32","pubTimestamp":1712064767,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时32分，Innate Pharma股票出现异动，股价大幅跳水5.97%。截至发稿，该股报2.52美元/股，成交量8977股，换手率0.01%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为1.36%。其相关个股中，Aditxt, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Aditxt, Inc.、Imunon, Inc.、Vbi Vaccines, Inc.较为活跃，换手率分别为462.86%、10.45%、10.12%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Aditxt, Inc.、Trevena, Inc.，振幅分别为48.62%、20.44%、11.75%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040221324787d59ea6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040221324787d59ea6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421850586","title":"Innate Pharma2023财年实现净利润-8.18百万美元，同比增加86.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421850586","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421850586?lang=zh_cn&edition=full","pubTime":"2024-03-22 15:18","pubTimestamp":1711091886,"startTime":"0","endTime":"0","summary":"12月31日，Innate Pharma公布财报，公告显示公司2023财年净利润为-8.18百万美元，同比增加86.57%；其中营业收入为56.11百万美元，同比增加7.68%，每股基本收益为-0.10美元。从资产负债表来看，Innate Pharma总负债1.46亿美元，其中短期债务9.87百万美元，资产负债比为1.40，流动比率为0.04。机构评级：截至2023年12月31日，当前有5家机构对Innate Pharma目标价做出预测，其中目标均价为8.07美元，其中最低目标价为5.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403221528538b5473e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403221528538b5473e3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421042990","title":"Innate Pharma盘中异动 快速下跌6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421042990","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421042990?lang=zh_cn&edition=full","pubTime":"2024-03-21 22:23","pubTimestamp":1711030987,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日22时23分，Innate Pharma股票出现波动，股价大幅跳水6.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Moolec Science Sa C/Wts 、Nextcure, Inc.涨幅较大，Scisparc Ltd.、Xtl生物制药、Bionomics Ltd Ads Each Rep 180 Ord Shs较为活跃，换手率分别为84.07%、21.32%、15.79%，振幅较大的相关个股有Portage Biotech Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为77.76%、66.00%、37.35%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321222308861e01fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321222308861e01fa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420320299","title":"Innate Pharma盘中异动 快速拉升5.44%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420320299","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420320299?lang=zh_cn&edition=full","pubTime":"2024-03-20 03:09","pubTimestamp":1710875379,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日03时09分，Innate Pharma股票出现波动，股价急速拉升5.44%。截至发稿，该股报2.52美元/股，成交量3316股，换手率0.00%，振幅2.03%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Fusion Pharmaceuticals Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Enliven Therapeutics, Inc.涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为928.52%、440.89%、403.44%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 、Nkgen Biotech Inc C/Wts 31/05/2028，振幅分别为83.33%、75.79%、74.36%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320030939791b7dbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320030939791b7dbf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420059224","title":"Innate Pharma盘中异动 早盘股价大跌6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420059224","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420059224?lang=zh_cn&edition=full","pubTime":"2024-03-18 22:58","pubTimestamp":1710773881,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日22时58分，Innate Pharma股票出现异动，股价急速下跌6.51%。截至发稿，该股报2.36美元/股，成交量3539股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Artelo Biosciences Inc C/Wts 20/06/2024 、Immuneering Corporation、Fresh2 Group Limited涨幅较大，Zyversa Therapeutics, Inc.、Immuneering Corporation、Tc Biopharm  Plc较为活跃，换手率分别为124.69%、27.23%、20.60%，振幅较大的相关个股有Artelo Biosciences Inc C/Wts 20/06/2024 、Immuneering Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为299.48%、67.02%、50.00%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031822580187939ea4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031822580187939ea4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419901589","title":"Innate Pharma盘中异动 股价大跌6.35%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419901589","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419901589?lang=zh_cn&edition=full","pubTime":"2024-03-15 23:52","pubTimestamp":1710517922,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日23时52分，Innate Pharma股票出现波动，股价急速跳水6.35%。截至发稿，该股报2.36美元/股，成交量666股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，杰龙、Better Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、知临集团较为活跃，换手率分别为303.34%、78.47%、26.05%，振幅较大的相关个股有Better Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、联拓生物，振幅分别为105.43%、63.00%、49.00%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152352028b3829fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403152352028b3829fb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419680923","title":"Innate Pharma盘中异动 早盘股价大跌5.77%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419680923","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419680923?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:50","pubTimestamp":1710337855,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时50分，Innate Pharma股票出现异动，股价快速跳水5.77%。截至发稿，该股报2.45美元/股，成交量100股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Nucana Plc、Kintara Therapeutics, Inc.涨幅较大，Kintara Therapeutics, Inc.、Nucana Plc、Revelation Biosciences, Inc.较为活跃，换手率分别为159.64%、52.45%、31.27%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Nucana Plc、Kintara Therapeutics, Inc.，振幅分别为82.54%、44.25%、29.55%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313215055861dddec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313215055861dddec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419566745","title":"Innate Pharma盘中异动 下午盘股价大涨5.11%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419566745","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419566745?lang=zh_cn&edition=full","pubTime":"2024-03-13 02:07","pubTimestamp":1710266852,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日02时07分，Innate Pharma股票出现波动，股价大幅上涨5.11%。截至发稿，该股报2.57美元/股，成交量1.3343万股，换手率0.02%，振幅6.75%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Regulus Therapeutics Inc.、Dermata Therapeutics Inc C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 涨幅较大，Regulus Therapeutics Inc.、Tc Biopharm  Plc、Scisparc Ltd.较为活跃，换手率分别为738.08%、325.03%、168.98%，振幅较大的相关个股有Regulus Therapeutics Inc.、Dermata Therapeutics Inc C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 ，振幅分别为131.16%、80.12%、74.77%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313020733861dd911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313020733861dd911&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418363057","title":"Innate Pharma盘中异动 早盘股价大跌7.41%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418363057","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418363057?lang=zh_cn&edition=full","pubTime":"2024-03-11 22:06","pubTimestamp":1710166004,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日22时06分，Innate Pharma股票出现波动，股价急速下挫7.41%。截至发稿，该股报2.50美元/股，成交量1819股，换手率0.00%，振幅1.85%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.17%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031122064487e77c99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031122064487e77c99&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417414829","title":"Innate Pharma盘中异动 急速下跌7.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417414829","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417414829?lang=zh_cn&edition=full","pubTime":"2024-03-05 22:31","pubTimestamp":1709649088,"startTime":"0","endTime":"0","summary":"北京时间2024年03月05日22时31分，Innate Pharma股票出现异动，股价大幅下跌7.60%。截至发稿，该股报2.43美元/股，成交量300股，换手率0.00%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Apogee Therapeutics, Inc.、Regenxbio Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、CASI制药较为活跃，换手率分别为196.94%、88.20%、43.81%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Ocean Biomedical, Inc.、Tevogen Bio Holdings Inc.，振幅分别为15.24%、11.03%、9.21%。Innate Pharma公司简介：Innate Pharma SA是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403052231288b08a03b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403052231288b08a03b&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innate-pharma.com/fr","stockEarnings":[{"period":"1week","weight":0.0317},{"period":"1month","weight":-0.0358},{"period":"3month","weight":0.0028},{"period":"6month","weight":0.0578},{"period":"1year","weight":-0.1458},{"period":"ytd","weight":-0.1046}],"compareEarnings":[{"period":"1week","weight":0.03},{"period":"1month","weight":0.0016},{"period":"3month","weight":0.0378},{"period":"6month","weight":0.1806},{"period":"1year","weight":0.2599},{"period":"ytd","weight":0.0944}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Innate Pharma S.A.成立于1999年9月23日，是一家生物技术公司，致力于发现，开发和商业化一流的治疗性抗体，这些抗体旨在利用免疫系统来治疗严重未满足医疗需求的肿瘤适应症。该公司在免疫肿瘤学的研究和开发方面拥有丰富的经验，是了解自然杀伤细胞或NK细胞生物学的先驱。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.039613},{"month":2,"riseRate":0.2,"avgChangeRate":-0.05047},{"month":3,"riseRate":0.4,"avgChangeRate":0.011353},{"month":4,"riseRate":0.4,"avgChangeRate":-0.037436},{"month":5,"riseRate":0.2,"avgChangeRate":-0.042769},{"month":6,"riseRate":0.75,"avgChangeRate":-0.010941},{"month":7,"riseRate":0.5,"avgChangeRate":0.00942},{"month":8,"riseRate":0.5,"avgChangeRate":-0.013469},{"month":9,"riseRate":0.25,"avgChangeRate":-0.017883},{"month":10,"riseRate":0.5,"avgChangeRate":0.033636},{"month":11,"riseRate":0.4,"avgChangeRate":0.019907},{"month":12,"riseRate":0.6,"avgChangeRate":0.122297}],"exchange":"NASDAQ","name":"Innate Pharma SA","nameEN":"Innate Pharma SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Innate Pharma SA,IPHA,Innate Pharma SA股票,Innate Pharma SA股票老虎,Innate Pharma SA股票老虎国际,Innate Pharma SA行情,Innate Pharma SA股票行情,Innate Pharma SA股价,Innate Pharma SA股市,Innate Pharma SA股票价格,Innate Pharma SA股票交易,Innate Pharma SA股票购买,Innate Pharma SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}